{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:44:03Z","timestamp":1767156243508,"version":"3.40.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ningxia Key Research and Development Plan Project","award":["2021BEG03115 to JH"],"award-info":[{"award-number":["2021BEG03115 to JH"]}]},{"name":"Ningxia Health Commission Project","award":["2023-NWKYT-020 to JH"],"award-info":[{"award-number":["2023-NWKYT-020 to JH"]}]},{"DOI":"10.13039\/501100004772","name":"Ningxia Natural Science Foundation","doi-asserted-by":"crossref","award":["2023AAC02070 to JH"],"award-info":[{"award-number":["2023AAC02070 to JH"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96010-w","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T07:36:30Z","timestamp":1744702590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urinary metabolomics reveals myo-inositol and (E)-Monocrotophos associate with prognosis in ACS comorbid with T2DM and preserved renal function"],"prefix":"10.1038","volume":"15","author":[{"given":"Mingyu","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yameng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miradil","family":"Dilshat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"96010_CR1","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMra1216063","volume":"368","author":"P Libby","year":"2013","unstructured":"Libby, P. Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med. 368, 2004\u20132013. https:\/\/doi.org\/10.1056\/NEJMra1216063 (2013).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"96010_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/ehjacc\/zuad107","volume":"13","author":"RA Byrne","year":"2023","unstructured":"Byrne, R. A. et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur. Heart J. Acute Cardiovasc. Care 13(1), 55\u2013161. https:\/\/doi.org\/10.1093\/ehjacc\/zuad107 (2023).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"96010_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.pcad.2019.07.003","volume":"62","author":"E Braunwald","year":"2019","unstructured":"Braunwald, E. Diabetes, heart failure, and renal dysfunction: The vicious circles. Prog. Cardiovasc. Dis. 62, 298\u2013302. https:\/\/doi.org\/10.1016\/j.pcad.2019.07.003 (2019).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"96010_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1536\/ihj.17-191","volume":"58","author":"R Naito","year":"2017","unstructured":"Naito, R. & Miyauchi, K. Coronary artery disease and type 2 diabetes mellitus. Int. Heart J. 58, 475\u2013480. https:\/\/doi.org\/10.1536\/ihj.17-191 (2017).","journal-title":"Int. Heart J."},{"key":"96010_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12944-020-01298-4","volume":"19","author":"Z Hamedifard","year":"2020","unstructured":"Hamedifard, Z. et al. The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Lipids Health Dis. 19, 112. https:\/\/doi.org\/10.1186\/s12944-020-01298-4 (2020).","journal-title":"Lipids Health Dis."},{"key":"96010_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","volume":"3","author":"AD Shah","year":"2015","unstructured":"Shah, A. D. et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1\u00b79 million people. Lancet Diabetes Endocrinol. 3, 105\u2013113. https:\/\/doi.org\/10.1016\/S2213-8587(14)70219-0 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"96010_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton, I. M. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ (Clin. Res. ed.) 321, 405\u2013412. https:\/\/doi.org\/10.1136\/bmj.321.7258.405 (2000).","journal-title":"BMJ (Clin. Res. ed.)"},{"key":"96010_CR8","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx, N. et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur. Heart J. 44, 4043\u20134140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192 (2023).","journal-title":"Eur. Heart J."},{"key":"96010_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1570161116666181024094337","volume":"18","author":"A Shehab","year":"2020","unstructured":"Shehab, A. et al. Diabetes and mortality in acute coronary syndrome: Findings from the gulf COAST registry. Curr. Vasc. Pharmacol. 18, 68\u201376. https:\/\/doi.org\/10.2174\/1570161116666181024094337 (2020).","journal-title":"Curr. Vasc. Pharmacol."},{"key":"96010_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12933-018-0793-x","volume":"17","author":"M Zhou","year":"2018","unstructured":"Zhou, M. et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovasc. Diabetol. 17, 147. https:\/\/doi.org\/10.1186\/s12933-018-0793-x (2018).","journal-title":"Cardiovasc. Diabetol."},{"key":"96010_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrcardio.2011.138","volume":"8","author":"JL Griffin","year":"2011","unstructured":"Griffin, J. L., Atherton, H., Shockcor, J. & Atzori, L. Metabolomics as a tool for cardiac research. Nat. Rev. Cardiol. 8, 630\u2013643. https:\/\/doi.org\/10.1038\/nrcardio.2011.138 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"96010_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41592-019-0710-6","volume":"17","author":"A Singh","year":"2020","unstructured":"Singh, A. Tools for metabolomics. Nat. Methods 17, 24. https:\/\/doi.org\/10.1038\/s41592-019-0710-6 (2020).","journal-title":"Nat. Methods"},{"key":"96010_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.118.002157","volume":"11","author":"DK Tobias","year":"2018","unstructured":"Tobias, D. K. et al. Circulating branched-chain amino acids and incident cardiovascular disease in a prospective cohort of US women. Circ. Genom. Precis. Med. 11, e002157. https:\/\/doi.org\/10.1161\/CIRCGEN.118.002157 (2018).","journal-title":"Circ. Genom. Precis. Med."},{"key":"96010_CR14","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1210\/jc.2018-00546","volume":"103","author":"F Ottosson","year":"2018","unstructured":"Ottosson, F., Smith, E., Melander, O. & Fernandez, C. Altered asparagine and glutamate homeostasis precede coronary artery disease and type 2 diabetes. J. Clin. Endocrinol. Metab. 103, 3060\u20133069. https:\/\/doi.org\/10.1210\/jc.2018-00546 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"96010_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2337\/dc19-1902","volume":"43","author":"G Ferrannini","year":"2020","unstructured":"Ferrannini, G. et al. coronary artery disease and type 2 diabetes: A proteomic study. Diabetes Care 43, 843\u2013851. https:\/\/doi.org\/10.2337\/dc19-1902 (2020).","journal-title":"Diabetes Care"},{"key":"96010_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003190","volume":"5","author":"WG Hunter","year":"2016","unstructured":"Hunter, W. G. et al. Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: Evidence for shared metabolic impairments in clinical heart failure. J. Am. Heart Assoc. 5, e003190. https:\/\/doi.org\/10.1161\/JAHA.115.003190 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"96010_CR17","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1021\/acs.jproteome.0c00879","volume":"20","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. Metabolic interactions and differences between coronary heart disease and diabetes mellitus: A pilot study on biomarker determination and pathogenesis. J. Proteome Res. 20, 2364\u20132373. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00879 (2021).","journal-title":"J. Proteome Res."},{"key":"96010_CR18","doi-asserted-by":"publisher","first-page":"9707513","DOI":"10.1155\/2019\/9707513","volume":"2019","author":"Y Qin","year":"2019","unstructured":"Qin, Y. et al. Relationship between random blood glucose, fasting blood glucose, and gensini score in patients with acute myocardial infarction. Biomed. Res. Int. 2019, 9707513. https:\/\/doi.org\/10.1155\/2019\/9707513 (2019).","journal-title":"Biomed. Res. Int."},{"key":"96010_CR19","doi-asserted-by":"publisher","first-page":"7938216","DOI":"10.1155\/2017\/7938216","volume":"2017","author":"B Stratmann","year":"2017","unstructured":"Stratmann, B. et al. Metabolomic signature of coronary artery disease in type 2 diabetes mellitus. Int. J. Endocrinol. 2017, 7938216. https:\/\/doi.org\/10.1155\/2017\/7938216 (2017).","journal-title":"Int. J. Endocrinol."},{"key":"96010_CR20","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1161\/CIR.0000000000001029","volume":"144","author":"M Gulati","year":"2021","unstructured":"Gulati, M. et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation 144, e368\u2013e454. https:\/\/doi.org\/10.1161\/CIR.0000000000001029 (2021).","journal-title":"Circulation"},{"key":"96010_CR21","doi-asserted-by":"publisher","unstructured":"Updates to the Standards of Medical Care in Diabetes-2018. Diabetes Care 41, 2045\u20132047. https:\/\/doi.org\/10.2337\/dc18-su09 (2018).","DOI":"10.2337\/dc18-su09"},{"key":"96010_CR22","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/eurheartj\/ehx138","volume":"38","author":"R Cavalcante","year":"2017","unstructured":"Cavalcante, R. et al. Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: A pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials. Eur. Heart J. 38, 1969\u20131977. https:\/\/doi.org\/10.1093\/eurheartj\/ehx138 (2017).","journal-title":"Eur. Heart J."},{"key":"96010_CR23","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/eurheartj\/ehx231","volume":"38","author":"K Mavromatis","year":"2017","unstructured":"Mavromatis, K. & King, S. B. SYNTAX scoring: growing stronger. Eur. Heart J. 38, 1978\u20131979. https:\/\/doi.org\/10.1093\/eurheartj\/ehx231 (2017).","journal-title":"Eur. Heart J."},{"key":"96010_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060\u20131083. https:\/\/doi.org\/10.1038\/nprot.2011.335 (2011).","journal-title":"Nat. Protoc."},{"key":"96010_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nprot.2010.50","volume":"5","author":"EJ Want","year":"2010","unstructured":"Want, E. J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 5, 1005\u20131018. https:\/\/doi.org\/10.1038\/nprot.2010.50 (2010).","journal-title":"Nat. Protoc."},{"key":"96010_CR26","doi-asserted-by":"publisher","first-page":"20535","DOI":"10.1038\/s41598-023-47783-5","volume":"13","author":"M Fu","year":"2023","unstructured":"Fu, M. et al. Multinomial machine learning identifies independent biomarkers by integrated metabolic analysis of acute coronary syndrome. Sci. Rep. 13, 20535. https:\/\/doi.org\/10.1038\/s41598-023-47783-5 (2023).","journal-title":"Sci. Rep."},{"key":"96010_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","volume":"32","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y. et al. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell Res. 32, 477\u2013490. https:\/\/doi.org\/10.1038\/s41422-022-00614-0 (2022).","journal-title":"Cell Res."},{"key":"96010_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 70, 761\u2013774. https:\/\/doi.org\/10.1136\/gutjnl-2019-319664 (2021).","journal-title":"Gut"},{"key":"96010_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/gutjnl-2020-323565","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut 71, 899\u2013909. https:\/\/doi.org\/10.1136\/gutjnl-2020-323565 (2022).","journal-title":"Gut"},{"key":"96010_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","volume":"33","author":"Y Gong","year":"2021","unstructured":"Gong, Y. et al. Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets. Cell Metab. 33, 51\u201364. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.012 (2021).","journal-title":"Cell Metab."},{"key":"96010_CR31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith, C. A., Want, E. J., O\u2019Maille, G., Abagyan, R. & Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779\u2013787. https:\/\/doi.org\/10.1021\/ac051437y (2006).","journal-title":"Anal. Chem."},{"key":"96010_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.taap.2014.02.012","volume":"276","author":"H Bahadar","year":"2014","unstructured":"Bahadar, H., Mostafalou, S. & Abdollahi, M. Current understandings and perspectives on non-cancer health effects of benzene: A global concern. Toxicol. Appl. Pharmacol 276, 83\u201394. https:\/\/doi.org\/10.1016\/j.taap.2014.02.012 (2014).","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"96010_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.pharmtox.44.101802.121704","volume":"44","author":"AA Caro","year":"2004","unstructured":"Caro, A. A. & Cederbaum, A. I. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol. 44, 27\u201342. https:\/\/doi.org\/10.1146\/annurev.pharmtox.44.101802.121704 (2004).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"96010_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/096032719601500510","volume":"15","author":"Y Shen","year":"1996","unstructured":"Shen, Y., Shen, H. M., Shi, C. Y. & Ong, C. N. Benzene metabolites enhance reactive oxygen species generation in HL60 human leukemia cells. Hum. Exp. Toxicol. 15, 422\u2013427. https:\/\/doi.org\/10.1177\/096032719601500510 (1996).","journal-title":"Hum. Exp. Toxicol."},{"key":"96010_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101129","volume":"4","author":"D Lv","year":"2023","unstructured":"Lv, D. et al. Targeting phenylpyruvate restrains excessive NLRP3 inflammasome activation and pathological inflammation in diabetic wound healing. Cell Rep. Med. 4, 101129. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101129 (2023).","journal-title":"Cell Rep. Med."},{"key":"96010_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115877","volume":"437","author":"DW Riggs","year":"2022","unstructured":"Riggs, D. W. et al. Environmental exposure to volatile organic compounds is associated with endothelial injury. Toxicol. Appl. Pharmacol 437, 115877. https:\/\/doi.org\/10.1016\/j.taap.2022.115877 (2022).","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"96010_CR37","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/nu12041151","volume":"12","author":"PV Dludla","year":"2020","unstructured":"Dludla, P. V. et al. The combination effect of aspalathin and phenylpyruvic acid-2-O-\u03b2-D-glucoside from rooibos against hyperglycemia-induced cardiac damage: An in vitro study. Nutrients 12, 1151. https:\/\/doi.org\/10.3390\/nu12041151 (2020).","journal-title":"Nutrients"},{"key":"96010_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn, S. E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46, 3\u201319. https:\/\/doi.org\/10.1007\/s00125-002-1009-0 (2003).","journal-title":"Diabetologia"},{"key":"96010_CR39","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017 (2018).","journal-title":"Physiol. Rev."},{"key":"96010_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2337\/diacare.13.3.244","volume":"13","author":"AR Saltiel","year":"1990","unstructured":"Saltiel, A. R. Second messengers of insulin action. Diabetes Care 13, 244\u2013256. https:\/\/doi.org\/10.2337\/diacare.13.3.244 (1990).","journal-title":"Diabetes Care"},{"key":"96010_CR41","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.3390\/ijms18102187","volume":"18","author":"S Dinicola","year":"2017","unstructured":"Dinicola, S. et al. Nutritional and acquired deficiencies in inositol bioavailability. Correlations with metabolic disorders. Int. J. Mol. Sci. 18, 2187. https:\/\/doi.org\/10.3390\/ijms18102187 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"96010_CR42","doi-asserted-by":"publisher","first-page":"F755","DOI":"10.1152\/ajprenal.00164.2015","volume":"309","author":"HH Chang","year":"2015","unstructured":"Chang, H. H. et al. Renal depletion of myo-inositol is associated with its increased degradation in animal models of metabolic disease. Am. J. Physiol. Renal Physiol. 309, F755\u2013F763. https:\/\/doi.org\/10.1152\/ajprenal.00164.2015 (2015).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"96010_CR43","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s00125-016-4024-2","volume":"59","author":"C von Toerne","year":"2016","unstructured":"von Toerne, C. et al. MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: The KORA F4 study. Diabetologia 59, 1882\u20131892. https:\/\/doi.org\/10.1007\/s00125-016-4024-2 (2016).","journal-title":"Diabetologia"},{"key":"96010_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/1535370214543064","volume":"240","author":"HH Chang","year":"2015","unstructured":"Chang, H. H., Choong, B., Phillips, A. R. & Loomes, K. M. The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol. Exp. Biolo. Med. (Maywood, NJ) 240, 8\u201314. https:\/\/doi.org\/10.1177\/1535370214543064 (2015).","journal-title":"Exp. Biolo. Med. (Maywood, NJ)"},{"key":"96010_CR45","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1017\/S000711451500121X","volume":"113","author":"ML Croze","year":"2015","unstructured":"Croze, M. L., G\u00e9lo\u00ebn, A. & Soulage, C. O. Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: Benefits of a dietary myo-inositol supplementation. Br. J. Nutr. 113, 1862\u20131875. https:\/\/doi.org\/10.1017\/S000711451500121X (2015).","journal-title":"Br. J. Nutr."},{"key":"96010_CR46","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1177\/153537020322800806","volume":"228","author":"JM Kawa","year":"2003","unstructured":"Kawa, J. M., Przybylski, R. & Taylor, C. G. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db\/db mouse and streptozotocin diabetic rat. Exp. Biol. Med.(Maywood, N. J.) 228, 907\u2013914. https:\/\/doi.org\/10.1177\/153537020322800806 (2003).","journal-title":"Exp. Biol. Med.(Maywood, N. J.)"},{"key":"96010_CR47","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0006-291X(02)00313-3","volume":"293","author":"TH Sun","year":"2002","unstructured":"Sun, T. H., Heimark, D. B., Nguygen, T., Nadler, J. L. & Larner, J. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem. Biophys. Res. Commun. 293, 1092\u20131098. https:\/\/doi.org\/10.1016\/S0006-291X(02)00313-3 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"96010_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.23876\/j.krcp.22.152","volume":"42","author":"S Kwon","year":"2023","unstructured":"Kwon, S. et al. Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: A targeted metabolomics study using nuclear magnetic resonance. Kidney Res. Clin. Pract. 42, 445\u2013459. https:\/\/doi.org\/10.23876\/j.krcp.22.152 (2023).","journal-title":"Kidney Res. Clin. Pract."},{"key":"96010_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2021.130051","volume":"275","author":"S Singh","year":"2021","unstructured":"Singh, S. et al. Toxicity and detoxification of monocrotophos from ecosystem using different approaches: A review. Chemosphere 275, 130051. https:\/\/doi.org\/10.1016\/j.chemosphere.2021.130051 (2021).","journal-title":"Chemosphere"},{"key":"96010_CR50","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3109\/15563650.2010.528425","volume":"48","author":"JV Peter","year":"2010","unstructured":"Peter, J. V. et al. Clinical profile and outcome of patients hospitalized with dimethyl and diethyl organophosphate poisoning. Clin. Toxicol. (Philadelphia, Pa) 48, 916\u2013923. https:\/\/doi.org\/10.3109\/15563650.2010.528425 (2010).","journal-title":"Clin. Toxicol. (Philadelphia, Pa)"},{"key":"96010_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4684-7071-0_5","volume":"139","author":"W M\u00fccke","year":"1994","unstructured":"M\u00fccke, W. Metabolism of monocrotophos in animals. Rev. Environ. Contam. Toxicol. 139, 59\u201365. https:\/\/doi.org\/10.1007\/978-1-4684-7071-0_5 (1994).","journal-title":"Rev. Environ. Contam. Toxicol."},{"key":"96010_CR52","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3109\/15563650.2015.1054500","volume":"53","author":"A Jose","year":"2015","unstructured":"Jose, A. et al. Estimation of Monocrotophos renal elimination half-life in humans. Clin. Toxicol. (Philadelphia, Pa) 53, 629\u2013632. https:\/\/doi.org\/10.3109\/15563650.2015.1054500 (2015).","journal-title":"Clin. Toxicol. (Philadelphia, Pa)"},{"key":"96010_CR53","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1177\/0960327120913080","volume":"39","author":"R Nagaraju","year":"2020","unstructured":"Nagaraju, R., Joshi, A., Vamadeva, S. & Rajini, P. S. Effect of chronic exposure to monocrotophos on white adipose tissue in rats and its association with metabolic dyshomeostasis. Hum. Exp. Toxicol. 39, 1190\u20131199. https:\/\/doi.org\/10.1177\/0960327120913080 (2020).","journal-title":"Hum. Exp. Toxicol."},{"key":"96010_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22506","volume":"34","author":"R Nagaraju","year":"2020","unstructured":"Nagaraju, R., Joshi, A., Vamadeva, S. G. & Rajini, P. S. Deregulation of hepatic lipid metabolism associated with insulin resistance in rats subjected to chronic monocrotophos exposure. J. Biochem. Mol. Toxicol. 34, e22506. https:\/\/doi.org\/10.1002\/jbt.22506 (2020).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"96010_CR55","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.aaa0672","volume":"347","author":"RJ Perry","year":"2015","unstructured":"Perry, R. J., Zhang, D., Zhang, X. M., Boyer, J. L. & Shulman, G. I. Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347, 1253\u20131256. https:\/\/doi.org\/10.1126\/science.aaa0672 (2015).","journal-title":"Science"},{"key":"96010_CR56","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.2337\/diabetes.51.11.3189","volume":"51","author":"HC Chen","year":"2002","unstructured":"Chen, H. C., Stone, S. J., Zhou, P., Buhman, K. K. & Farese, R. V. Jr. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue. Diabetes 51, 3189\u20133195. https:\/\/doi.org\/10.2337\/diabetes.51.11.3189 (2002).","journal-title":"Diabetes"},{"key":"96010_CR57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuro.2012.01.008","volume":"33","author":"AI Kazi","year":"2012","unstructured":"Kazi, A. I. & Oommen, A. Monocrotophos induced oxidative damage associates with severe acetylcholinesterase inhibition in rat brain. Neurotoxicology 33, 156\u2013161. https:\/\/doi.org\/10.1016\/j.neuro.2012.01.008 (2012).","journal-title":"Neurotoxicology"},{"key":"96010_CR58","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/15563650.2018.1515438","volume":"57","author":"RM Gifford","year":"2019","unstructured":"Gifford, R. M. et al. Short-term glucose dysregulation following acute poisoning with organophosphorus insecticides but not herbicides, carbamate or pyrethroid insecticides in South Asia. Clin. Toxicol. (Philadelphia, Pa) 57, 254\u2013264. https:\/\/doi.org\/10.1080\/15563650.2018.1515438 (2019).","journal-title":"Clin. Toxicol. (Philadelphia, Pa)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96010-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96010-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96010-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T20:01:26Z","timestamp":1745092886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96010-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96010"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96010-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12905"}}